Compounds > cucumarioside
Page last updated: 2024-11-10

cucumarioside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cucumarioside: from Cucumaria (sea cucumbers); RN given refers to cpd with unknown MF [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3085992
MeSH IDM0103904

Synonyms (2)

Synonym
74434-21-2
cucumarioside

Research Excerpts

Overview

Cucumarioside A(2)-2 is a pentaoside having glucose as a third monosaccahride unit.

ExcerptReferenceRelevance
"Cucumarioside A(2)-2 is a pentaoside having glucose as a third monosaccahride unit."( Differential effects of triterpene glycosides, frondoside A and cucumarioside A2-2 isolated from sea cucumbers on caspase activation and apoptosis of human leukemia cells.
Avilov, SA; Fedorov, SN; Jin, JO; Kwak, JY; Park, JI; Rasskazov, VA; Shastina, VV; Shin, SW; Stonik, VA; Xu, Q, 2009)		1.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (11.11)18.7374
1990's4 (22.22)18.2507
2000's3 (16.67)29.6817
2010's8 (44.44)24.3611
2020's1 (5.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.68

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.68 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index4.97 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.68)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other26 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
3-o-methylglucose
3-O-Methylglucose: A non-metabolizable glucose analogue that is not phosphorylated by hexokinase. 3-O-Methylglucose is used as a marker to assess glucose transport by evaluating its uptake within various cells and organ systems. (J Neurochem 1993;60(4):1498-504). 3-O-methyl-D-glucose : A D-aldohexose that is D-glucose in which the hydrogen of the hydroxy group at position 3 has been substituted by a methyl group. It is a non-metabolisable glucose analogue that is not phosphorylated by hexokinase and is used as a marker to assess glucose transport by evaluating its uptake within various cells and organ systems.		1.9910D-aldohexose derivative
fluorescein-5-isothiocyanate
Fluorescein-5-isothiocyanate: Fluorescent probe capable of being conjugated to tissue and proteins. It is used as a label in fluorescent antibody staining procedures as well as protein- and amino acid-binding techniques.. fluorescein 5-isothiocyanate : The 5-isomer of fluorescein isothiocyanate. Acts as a fluorescent probe capable of being conjugated to tissue and proteins; used as a label in fluorescent antibody staining procedures as well as protein- and amino acid-binding techniques.		2.0510fluorescein isothiocyanate
glycosides
[no description available]		4.27180
beta-escin
[no description available]		2.4720
cucumarioside a2-2
cucumarioside A2-2: isolated from Cucumaria japonica; structure in first source		7.0510
holothurin
Holothurin: A highly toxic saponin occurring in HOLOTHUROIDEA. This marine toxin is an anionic surfactant, hemolyzing ERYTHROCYTES.		2.3820
frondoside a
frondoside A: from the North Atlantic commercially harvested sea cucumber Cucumaria frondosa		7.0510
ConditionIndicatedRelationship StrengthStudiesTrials
Breast Cancer
[description not available]		02.610
Breast Neoplasms
Tumors or cancer of the human BREAST.		02.610
Carcinoma, Ehrlich Tumor
A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.		02.5220
Leucocythaemia
[description not available]		02.0510
Leukemia
A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)		07.0510
Extravascular Hemolysis
[description not available]		02.9540
Hemolysis
The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.		02.9540
Delayed Hypersensitivity
[description not available]		02.0310
Infections, Staphylococcal
[description not available]		02.0310
Far East Scarlet-like Fever
[description not available]		02.0310
Staphylococcal Infections
Infections with bacteria of the genus STAPHYLOCOCCUS.		02.0310
Salmonella Infections, Animal
Infections in animals with bacteria of the genus SALMONELLA.		01.9610
Abnormalities, Autosome
[description not available]		01.9710
E coli Infections
[description not available]		01.9710
Opportunistic Infections
An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.		01.9710
Infections, Pseudomonas
[description not available]		01.9710
Infections, Proteus
[description not available]		01.9710
Escherichia coli Infections
Infections with bacteria of the species ESCHERICHIA COLI.		01.9710
Pseudomonas Infections
Infections with bacteria of the genus PSEUDOMONAS.		01.9710